---
title: "Biocytogen (688796.SH) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688796.SH/norm.md"
symbol: "688796.SH"
name: "Biocytogen"
parent: "https://longbridge.com/en/quote/688796.SH.md"
datetime: "2026-05-20T08:16:59.493Z"
locales:
  - [en](https://longbridge.com/en/quote/688796.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688796.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688796.SH/norm.md)
---

# Biocytogen (688796.SH) — Financial Reports

## Income Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.2300 | 0.1380 | 0.1670 | 0.0606 | -0.0300 |
| ROE | 18.67% | 15.00% | - | 10.76% | -6.35% |
| Revenue | 433.06M | 437.93M | 319.92M | 310.48M | 249.34M |
| Net income | 104.03M | 59.07M | 66.13M | 24.00M | -13.25M |
| Operating income | 133.93M | 75.31M | 34.57M | 50.67M | 10.98M |
| Gross margin | 78.88% | 76.67% | 66.20% | 77.74% | 72.82% |
| Net margin | 24.02% | 13.49% | 20.67% | 7.73% | -5.31% |
| Profit quality | 92.44% | 70.07% | 58.27% | 49.81% | 32.26% |

## Balance Sheet (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 3.68B | 3.72B | 2.44B | 2.49B | - |
| Leverage | 1.61 | 1.71 | 2.49 | 2.77 | - |
| BVPS | 5.11 | 4.87 | 2.44 | 2.23 | 2.09 |
| Turnover | - | 0.4491 | - | 0.4841 | - |
| Cash & STI | 1.23B | 1.59B | 351.60M | 486.84M | 403.85M |
| Inv & Rec | 180.31M | 169.87M | 148.43M | 7.65M | - |
| LT assets | 1.48B | 1.24B | 1.23B | 1.35B | - |
| Net debt | -237.40M | -1.00B | 246.71M | 127.34M | 166.43M |

## Cash Flow Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 144.88M | 107.48M | 59.34M | 101.72M | 34.03M |
| Investing CF | -510.53M | 148794.00 | -102.11M | -41.45M | -11.26M |
| Financing CF | -316.16M | 1.12B | -56.02M | -43.64M | -15.93M |
| Free CF | -455.92M | 314.36M | - | 68.01M | - |
| OCF coverage | 42.41% | 57.69% | 78.93% | 89.17% | 29.87% |
| Repaid & issued | 215.94M | 27.00M | 39.00M | 91.14M | 109.27M |
| CapEx | -106.05M | -21.75M | -34.35M | -15.86M | -11.28M |